Search

Contexte: Les donnees de surveillance du cancer sont essentielles pour mieux comprendre les lacunes et les progres realises dans la lutte contre le cancer. Nous avons cherche a resumer les repercussions prevues du cancer au Canada en 2024, en effectuant des projections sur les nouveaux cas de cancer et les deces par cancer, par sexe et par province ou territoire, pour tous les ages confondus. Methodes: Nous avons obtenu les donnees sur les nouveaux cas de cancer (c.-a-d., l'incidence, 1984-2019) et les deces par cancer (c.-a-d., la mortalite, 1984-2020) du Registre canadien du cancer et de la Base canadienne de donnees de l'etat civil--Deces, respectivement. Nous avons projete les chiffres et les taux d'incidence du cancer et de mortalite jusqu'en 2024 pour 23 types de cancer, par sexe et par province ou territoire. Nous avons calcule des taux normalises selon l'age au moyen de donnees de la population type canadienne de 2011. Resultats: En 2024, les nombres de nouveaux cas de cancer et de deces causes par le cancer devraient atteindre 247 100 et 88 100, respectivement. Le taux d'incidence normalise selon l'age (TINA) et le taux de mortalite normalise selon l'age (TMNA) devraient diminuer legerement par rapport aux annees precedentes, tant chez les hommes que chez les femmes, avec des taux plus eleves chez les hommes (TINA de 562,2 pour 100 000, et TMNA de 209,6 pour 100 000 chez les hommes; TINA de 495,9 pour 100 000 et TMNA de 152,8 pour 100 000 chez les femmes). Les TINA et les TMNA de plusieurs cancers courants devraient continuer a diminuer (p. ex., cancer du poumon, cancer colorectal et cancer de la prostate), tandis que ceux de plusieurs autres cancers devraient augmenter (p. ex., cancer du foie et des voies biliaires intrahepatiques, cancer du rein, melanome et lymphome non hodgkinien). Interpretation: Bien que l'incidence globale du cancer et la mortalite connexe sont en declin, il devrait y avoir une augmentation des nouveaux cas et des deces au Canada en 2024, en grande partie en raison de la croissance et du vieillissement de la population. Les efforts en matiere de prevention, de depistage et de traitement ont attenue les repercussions de certains cancers, mais ces projections a court terme soulignent l'effet potentiel du cancer sur les gens et les systemes de soins de sante au Canada., Le cancer a une incidence considerable sur la vie des personnes vivant au Canada et sur les systemes de soins de sante canadiens (1,2). Selon les estimations anterieures, 45% de [...]

Background: Cancer surveillance data are essential to help understand where gaps exist and progress is being made in cancer control. We sought to summarize the expected impact of cancer in Canada in 2024, with projections of new cancer cases and deaths from cancer by sex and province or territory for all ages combined. Methods: We obtained data on new cancer cases (i.e., incidence, 19842019) and deaths from cancer (i.e., mortality, 1984-2020) from the Canadian Cancer Registry and Canadian Vital Statistics Death Database, respectively. We projected cancer incidence and mortality counts and rates to 2024 for 23 types of cancer, overall, by sex, and by province or territory. We calculated age-standardized rates using data from the 2011 Canadian standard population. Results: In 2024, the number of new cancer cases and deaths from cancer are expected to reach 247 100 and 88 100, respectively. The age-standardized incidence rate (ASIR) and mortality rate (ASMR) are projected to decrease slightly from previous years for both males and females, with higher rates among males (ASIR 562.2 per 100 000 and ASMR 209.6 per 100 000 among males; ASIR 495.9 per 100 000 and ASMR 152.8 per 100 000 among females). The ASIRs and ASMRs of several common cancers are projected to continue to decrease (i.e., lung, colorectal, and prostate cancer), while those of several others are projected to increase (i.e., liver and intrahepatic bile duct cancer, kidney cancer, melanoma, and non-Hodgkin lymphoma). Interpretation: Although the overall incidence of cancer and associated mortality are declining, new cases and deaths in Canada are expected to increase in 2024, largely because of the growing and aging population. Efforts in prevention, screening, and treatment have reduced the impact of some cancers, but these short-term projections highlight the potential effect of cancer on people and health care systems in Canada., Cancer has a substantial impact on the lives of people living in Canada and on Canadian health care systems. (1,2) Previous estimates suggest that 45% of all people in Canada [...]

Contexte : La surveillance reguliere du cancer est essentielle pour comprendre ou des progres sont realises et ou il faut en faire plus. Nous avons cherche a donner un apercu du fardeau attendu du cancer au Canada, en 2022. Methodes : Nous avons obtenu les nouvelles donnees sur l'incidence du cancer a partir du Systeme national de declaration des cas de cancer (1984-1991) et du Registre canadien du cancer (1992-2018). Les donnees sur la mortalite (1984-2019) sont extraites de la Base canadienne de donnees sur les deces de la Statistique de l'etat civil. Nous avons projete les nombres et les taux d'incidence du cancer et de mortalite jusqu'en 2022 pour 22 types de cancer, par sexe et par province ou territoire. Les taux ont ete normalises selon l'age de la population type canadienne de 2011. Resultats : On estime a 233900 le nombre de nouveaux cas de cancer et a 85 100 le nombre de deces des suites du cancer au Canada en 2022. Nous nous attendons a ce que les cancers les plus frequemment diagnostiques soient le cancer du poumon en general (30 000), le cancer du sein chez les femmes (28 600) et le cancer de la prostate chez les hommes (24 600). De plus, le cancer du poumon devrait etre la principale cause de deces lie au cancer, representant 24,3 % de l'ensemble des deces par cancer, suivi des cancers colorectal (11,0 %o), du pancreas (6,7 %o) et du sein (6,5 %o). On s'attend generalement a ce que les taux d'incidence et de mortalite soient plus eleves dans les provinces de l'est du Canada que dans celles de l'ouest. Interpretation : Bien que les taux globaux de cancer soient en baisse, le nombre de cas et de deces continue de grimper, en raison de la croissance demographique et du vieillissement demographique. Le fardeau eleve projete du cancer du poumon indique qu'il est necessaire de renforcer la lutte contre le tabagisme et d'ameliorer la detection precoce et le traitement. Les progres realises en matiere de depistage et de traitement du cancer du sein et du cancer colorectal expliquent probablement la diminution continue de leur fardeau. Les progres limites en matiere de detection precoce et de nouveaux traitements du cancer du pancreas expliquent pourquoi on s'attend a ce qu'il soit la troisieme cause de deces par cancer au Canada., Les consequences du cancer sur la population et les systemes de soins de sante canadiens sont considerables. Le cancer est la principale cause de deces au Canada (1,2) et des [...]

Background: Regular cancer surveillance is crucial for understanding where progress is being made and where more must be done. We sought to provide an overview of the expected burden of cancer in Canada in 2022. Methods: We obtained data on new cancer incidence from the National Cancer Incidence Reporting System (1984-1991) and Canadian Cancer Registry (1992-2018). Mortality data (1984-2019) were obtained from the Canadian Vital Statistics--Death Database. We projected cancer incidence and mortality counts and rates to 2022 for 22 cancer types by sex and province or territory. Rates were age standardized to the 2011 Canadian standard population. Results: An estimated 233900 new cancer cases and 85100 cancer deaths are expected in Canada in 2022. We expect the most commonly diagnosed cancers to be lung overall (30000), breast in females (28600) and prostate in males (24600). We also expect lung cancer to be the leading cause of cancer death, accounting for 24.3% of all cancer deaths, followed by colorectal (11.0%), pancreatic (6.7%) and breast cancers (6.5%). Incidence and mortality rates are generally expected to be higher in the eastern provinces of Canada than the western provinces. Interpretation: Although overall cancer rates are declining, the number of cases and deaths continues to climb, owing to population growth and the aging population. The projected high burden of lung cancer indicates a need for increased tobacco control and improvements in early detection and treatment. Success in breast and colorectal cancer screening and treatment likely account for the continued decline in their burden. The limited progress in early detection and new treatments for pancreatic cancer explains why it is expected to be the third leading cause of cancer death in Canada., The impact of cancer on the Canadian population and health care systems is substantial. Cancer is the leading cause of death in Canada (1,2) and previous estimates have shown that [...]

BACKGROUND: Cancer projections to the current year help in policy development, planning of programs and allocation of resources. We sought to provide an overview of the expected incidence and mortality of cancer in Canada in 2020 in follow-up to the Canadian Cancer Statistics 2019 report. METHODS: We obtained incidence data from the National Cancer Incidence Reporting System (1984-1991) and Canadian Cancer Registry (1992-2015). Mortality data (1984-2015) were obtained from the Canadian Vital Statistics --Death Database. All databases are maintained by Statistics Canada. Cancer incidence and mortality counts and age-standardized rates were projected to 2020 for 23 cancer types by sex and geographic region (provinces and territories) for all ages combined. RESULTS: An estimated 225 800 new cancer cases and 83 300 cancer deaths are expected in Canada in 2020. The most commonly diagnosed cancers are expected to be lung overall (29 800), breast in females (27 400) and prostate in males (23 300). Lung cancer is also expected to be the leading cause of cancer death, accounting for 25.5% of all cancer deaths, followed by colorectal (11.6%), pancreatic (6.4%) and breast (6.1%) cancers. Incidence and mortality rates will be generally higher in the eastern provinces than in the western provinces. INTERPRETATION: The number of cancer cases and deaths remains high in Canada and, owing to the growing and aging population, is expected to continue to increase. Although progress has been made in reducing deaths for most major cancers (breast, prostate and lung), there has been limited progress for pancreatic cancer, which is expected to be the third leading cause of cancer death in Canada in 2020. Additional efforts to improve uptake of existing programs, as well as to advance research, prevention, screening and treatment, are needed to address the cancer burden in Canada., Cancer poses a large and growing impact on the Canadian population and health care system. Nearly half of Canadians are expected to receive a diagnosis of cancer in their lifetime [...]